Ligand profile
HTW
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00667 — Glycogen phosphorylase
Identifiers
Database identifiers and provenance.
- Ligand ID
HTW- PDB
6qa7- UniProt (similar protein)
P00489- Target protein
- KP13_00667
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 131.6
- −1 ≤ LogP ≤ 5 -1.11
- MW ≤ 500 Da 358.4
- LogP ≤ 5 -1.11
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 131.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc2c(c1)cccc2C3=N[C@]4([C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C(=O)N3c1ccc2c(c1)cccc2C3=N[C@]4([C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C(=O)N3
InChI=1S/C18H18N2O6/c21-8-12-13(22)14(23)15(24)18(26-12)17(25)19-16(20-18)11-7-3-5-9-4-1-2-6-10(9)11/h1-7,12-15,21-24H,8H2,(H,19,20,25)/t12-,13-,14+,15-,18+/m1/s1InChI=1S/C18H18N2O6/c21-8-12-13(22)14(23)15(24)18(26-12)17(25)19-16(20-18)11-7-3-5-9-4-1-2-6-10(9)11/h1-7,12-15,21-24H,8H2,(H,19,20,25)/t12-,13-,14+,15-,18+/m1/s1
VIYRJCLPOZQRSZ-NSIVTLKISA-NVIYRJCLPOZQRSZ-NSIVTLKISA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00343
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand HTW →
- PDB RCSB structure 6qa7 →
- UniProt UniProt P00489 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “HTW”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00667.
PDB 115
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).